Savara (SVRA) Debt Ratio (2015 - 2026)
Savara (SVRA) reported Debt Ratio of 0.14 for Q1 2026, down 13.02% year-over-year from 0.16 in Q1 2025, and up 14.95% quarter-over-quarter from 0.12 in Q4 2025.
Savara (SVRA) Debt Ratio (2015 - 2026) Analysis & Trends
Savara (SVRA) has 12 years of Debt Ratio data on file, last reported at 0.14 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.14, down 13.02% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.14 (down 13.02% YoY), and the FY2025 annual result was 0.12, down 5.63% from the prior year.
- Debt Ratio improved to 0.14 in Q1 2026 per SVRA's latest filing, from 0.12 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.22 in Q2 2023 and troughed at 0.11 in Q3 2024.
- A 5-year average of 0.16 and a median of 0.17 in 2022 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio slipped 22.97% in 2024, then soared 90.07% in 2025.
- A 5-year view of Debt Ratio shows it stood at 0.19 in 2022, then declined by 20.47% to 0.15 in 2023, then fell by 15.73% to 0.13 in 2024, then decreased by 5.63% to 0.12 in 2025, then rose by 14.95% to 0.14 in 2026.
- Business Quant data shows SVRA's Debt Ratio at 0.14 in Q1 2026, 0.12 in Q4 2025, and 0.21 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.18 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.20 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.17 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.13 |